Drug Shortage Report for SHINGRIX
Report ID | 193889 |
Drug Identification Number | 02468425 |
Brand name | SHINGRIX |
Common or Proper name | Herpes Zoster vaccine |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | VARICELLA-ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN |
Strength(s) | 50MCG |
Dosage form(s) | SUSPENSION |
Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
Packaging size | 10's |
ATC code | J07BK |
ATC description | |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2023-06-14 |
Estimated end date | 2023-07-14 |
Actual end date | 2023-07-14 |
Shortage status | Resolved |
Updated date | 2023-07-15 |
Company comments | Delay in Supply. Supply available for public programs. Supply unavailable for the private market. SHINGRIX is available to order in packages of 1 |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2023-07-15 | English | Compare |
v9 | 2023-07-14 | French | Compare |
v8 | 2023-07-14 | English | Compare |
v7 | 2023-06-16 | French | Compare |
v6 | 2023-06-16 | English | Compare |
v5 | 2023-06-15 | English | Compare |
v4 | 2023-06-12 | French | Compare |
v3 | 2023-06-12 | English | Compare |
v2 | 2023-06-08 | French | Compare |
v1 | 2023-06-08 | English | Compare |
Showing 1 to 10 of 10